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Abstract
OBJECTIVE: To investigate the effects of Zhuyesh-
igao granule (ZSG) on tumor necrosis factor-α
(TNF-α), interleukin-1 (IL-1), IL-2, IL-6, and IL-8 in
rats with radiation esophagitis.
METHODS: Fifty Wistar rats were randomly divid-
ed into five groups (10 rats in each group): con-
trol (without radiation), saline-treated, and low,
medium, and high-dose ISG-treated groups. Rats
were given normal saline (10 mL/kg) or 1.15, 2.3,
or 4.6 g/kg ZSG by intragastric administration once
a day for 7 days. A rat model of radiation esophagi-
tis was established by local irradiation of Co60
(490.25 cGy/min, totaling 30 Gy). The administra-
tion of ZSG was continued for another 7 days and
on the 7th day post-irradiation, inferior vena cava
blood was collected. The serum was separated, and
TNF-α, IL-1, IL-2, IL-6, and IL-8 protein levels were
determined.
RESULTS: Inflammatory response factors were
found in the serum of each group. However, levels
in ZSG-treated groups were significantly lower than
in the saline-treated group (P<0.05).
CONCLUSION: ZSG may prevent the development
of radiation esophagitis, perhaps by inhibiting the
generation and release of the inflammatory re-
sponse factors TNF-α, IL-1, IL-2, IL-6, and IL-8.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Radiotherapy has been widely adopted in clinical prac-
tice as one of the main therapeutic methods for malig-
nant tumors. However, a severe side effect is that it
may cause radiation esophagitis, which is the most
common complication of thoracic cancer following ra-
diation therapy. The pathological changes include
esophageal mucosal hyperemia, edema, and ulcers,
with the main clinical symptom being difficulty in
swallowing with a retrosternal burning sensation.1 Seri-
ous radiation esophagitis makes patients resistant to
and afraid of radiotherapy, which will impact the cura-
tive effect. At present, there are no effective methods
for the prevention and control of radiation esophagitis.
In recent years, studies have shown that inflammatory
response factors play an important role in pathological
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damage resulting from radiation.2,3 Through long-term
clinical practice under the guidance of Traditional Chi-
nese Medicine, we have tested the use of Zhuyeshigao
decoction for the prevention and treatment of radia-
tion esophagitis, and achieved satisfactory therapeutic
results.4,5
Our previous research has shown that Zhuyeshigao
granule (ZSG) have potential for preventing and treat-
ing radiation esophagitis.6 The present study extends
our previous studies. We used ZSG to intervene with
radiation esophagitis in rats. By observing the inflam-
matory response factors interleukins-1 (IL-1), IL-2,
IL-6, IL-8 and tumor necrosis factor-α (TNF-α), we
sought to explore the potential mechanisms of ZSG.
MATERIALS ANDMETHODS
Animals
Male Wistar rats [n=50; (180±20) g] were purchased
from the Laboratory Animal Center of the Chinese
Academy of Military Medical Sciences (Beijing, Chi-
na). All animal care and experimental protocols com-
plied with the Animal Management Rule issued by the
Ministry of Health, People's Republic of China (PLA)
(Documentation 55, 2001). Animals were maintained
at 23℃±1℃, with 75% humidity.
Drug preparation
ZSG were produced by the Drug Manufacturing
Room of Chinese PLA General Hospital. The ingredi-
ents were Zhuye (Folium Phyllostachydis Henonis) 1000 g,
Shigao (Gypsum Fibrosum) 3000 g, Renshen (Radix
Ginseng) 500 g, Maidong (Radix Ophiopogonis Japoni-
ci) 3000 g, Banxia (Rhizoma Pinelliae) 1500 g, and
Gancao (Radix Glycyrrhizae) 600 g. All herbal medi-
cines were provided by Tong Ren Tang (Beijing Chi-
na), with quality control by Chinese Pharmacopoeia.
We decocted the mixture twice, each time for 2 h, un-
der normal temperature and pressure conditions, using
a can for extraction of the Traditional Chinese Medi-
cine. Extracts were dissolved in 10× water volume and
mixed. The extracts were further concentrated into sol-
ids with a vacuum recycling evaporator under a low
temperature (60℃-65℃ ). The solid was then sprayed,
dried, and grained by a spraying and drying granulator.
Finally, a particles-separated packaging machine was
used to separate the granules into bags, with 12 g in
each bag, equivalent to 30 g crude drug. For rats, 1.15,
2.3, and 4.6 g/kg ZSG were the low, medium, and
high doses, which were 2.5, 5, and 10 times the nor-
mal dose, respectively, for a 70 kg adult.
Reagent and instrument
The Co60 irradiation rig (Radiology and Radiation
Protection Institute of Chinese Academy of Military
Medical Sciences, Beijing, China), centrifuge, and
pathologic microtome were obtained using a BX40 mi-
croscope (Olympus, Tokyo, Japan). Mitotic image ac-
quisition and processing systems were obtained from
China-Canada joint venture (Xinzhen equipment Co.,
Ltd., Shanghai, China). Rats were treated with 3%
pentobarbital sodium, and iodine [125I] radioimmuno-
assay kit (Taiyuan Satellite Pharmaceutical Co., Ltd.,
Shanxi, China).
Grouping and treatment
All the animals were labeled with a number according
to their weight and completely randomly divided in-
to five groups (10 rats in each group): control (with-
out radiation, but with 10 mL/kg normal saline given
by intragastric administration once daily), saline-treat-
ed (undergoing radiation and with 10 mL/kg normal
saline given by intragastric administration once dai-
ly), and low, medium and high-dose ZSG-treated
groups (undergoing radiation and with 1.15, 2.3, or
4.6 g/kg ZSG by intragastric administration once a
day for 7 days).
Radiation
Based on preliminary experiments, we found that radia-
tion esophagitis developed when the cobalt irradiation
was over 490 cGy/min and the total radiation dose was
more than 30 Gy. We also found that drugs were inef-
fective under too large a dose of radiation (35Gy) con-
dition.7 Based on the above observations, we chose the
following irradiation protocol. Rats were anesthetized
with 3% sodium pentobarbital with their limbs fixed
on the irradiation shelf and positioned 3 m away from
the cobalt source. Using a 1-m-high irradiation stage,
the irradiation fields were 3 mm superior to the lower
thyroid section, adjusted by a teeth-hanging line. The
ventral side of the upper superior section faced the irra-
diation hole of a lead brick (30 mm×20 mm×5 mm),
with the rest shielded with a double lead brick. The
one-time radiation dose rate was 490.25 cGy/min, and
the total dose was 30 Gy, with the radiation time last-
ing 6 min and 13 s.
Serum collection and immunoassay
On the 7th day post-radiation, all rats were anesthe-
tized by 3% sodium pentobarbital, and inferior vena
cava blood (5 mL) collected. Blood was centrifuged
(3000 rpm) for 15 min. Serum (1 mL) was collected
and IL-1, IL-2, IL-6, IL-8, and TNF-α protein levels
were determined by iodine [I125] radioimmunoassay.
Statistics
SAS 9.1 software (SAS Institute Inc., Cary, NC, USA)
was used for statistical analysis. For multiple-group
comparisons, one way analysis of variance followed by
Newman-Keuls post hoc analysis was performed. The
index between the groups was compared by HSD
(Tukey's student range) test, and P<0.05 was consid-
ered to be statistically significant. The data were ex-
pressed as mean±SD. For multiple-group comparisons,
the HSD test was applied.
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RESULTS
Serum levels of inflammation response factors
(IL-1, -2, -6, -8, and TNF-α) were tested and com-
pared. All factors were significantly higher in the sa-
line-treated group (all P<0.05), but no differences were
found in the high-dose ZSG-treated group (all P>
0.05) (Table 1). Compared with the saline-treated
group, all factors were significantly lower in all three
ZSG-treated groups (all P<0.05). We also observed
that compared with the low-dose ZSG-treated group,
the medium and high-dose groups had lower levels of
all factors (all P<0.05). IL-6, IL-8, and TNF-α levels
were significantly higher in the low-dose relative to the
medium-dose ZSG-treated group (P<0.05), with no
differences in IL-1 and IL-2 levels (P>0.05). In addi-
tion, IL-1, IL-2, IL-6, and TNF-α levels were elevated
in the medium-dose ZSG-treated group relative to
high-dose ZSG-treated rats (P<0.05).
DISCUSSION
The pathogenic mechanism of radiation esophagitis is
unknown. Studies have shown that radiation may in-
duce the release of pro-inflammatory cytokines, such as
IL-1, IL-2, IL-6, IL-8 and TNF-α, from normal
healthy tissues. These pro-inflammatory cytokines pro-
mote the release of neutrophils, enhance neutrophil ac-
tivity and macrophage killer function, induce mononu-
clear cells and polymorphonuclear (PMN) cell infiltra-
tion of the inflammatory zone to phagocytose dam-
aged cells, and cause damage to normal tissues. Re-
search into human disease and effective treatments de-
pends on the establishment and application of animal
models that are similar to the pathological changes of
human diseases. Our research has shown that ZSG
may play an active role in preventing radiation esopha-
gitis development. We used thin layer chromatography
methods to control the quality of ZSG according to
the 2010 version of Chinese Pharmacopoeia.8
IL-1 is a pro-inflammatory cytokine that activates
many immunocytes and inflammatory cells. It also pro-
motes agglutination and adhesion of PMN cells, acti-
vates vascular endothelial cells, increases release of in-
flammatory mediators, increases vascular permeability,
and destroys endothelial cell integrity, which leads to
tissue damage.9,10 T cells are the primary producers of
IL-2, which affects autocrine and paracrine mecha-
nisms, enhances T and B cell proliferation and activa-
tion, promotes cytokine generation, stimulates NK cell
proliferation, enhances NK killer cell cytokine produc-
tion, induces lymphokines that activate killer cells, pro-
motes B cell proliferation and antibody secretion, acti-
vates macrophages, and induces generation of TNF-α
and other pro-inflammatory cytokines.11,12 IL-6 is an
important mediator of neuroinflammation, which in-
duces development of the acute phase of the inflamma-
tory response. IL-6 also induces leucocyte agglutina-
tion and tissue damage.13 IL-8 impacts PMN chemotax-
is and promotes morphological changes in neutrophils.
IL-8 also triggers degranulation, expression of surface
adhesion molecules and production of reactive oxygen
species, and promotes basophil chemotaxis and hista-
mine and leukotriene release, hence it induces tissue in-
jury and leads to inflammation.14
We applied the Honest Significant Difference test for
statistical analysis. The Tukey test is designed specifical-
ly for pair-wise comparisons based on the studentized
range, sometimes called the "honestly significant differ-
ence test," which controls the MEER when the sample
sizes are equal. The Tukey or Tukey-Kramer method is
provided by the TUKEY option in the MEANS state-
ment and the ADJUST=TUKEY option in the
LSMEANS statement. The Tukey-Kramer method is
more powerful than the Bonferroni, Sidak, or Scheffé
methods for pair-wise comparisons.
The present study suggests that the serum IL-1, IL-2,
IL-6, and IL-8 protein levels following low, medium,
and high-dose ZSG-treatments are lower than those fol-
lowing saline treatment (P<0.05). The results demon-
strate that ZSG may prevent the development of radia-
tion esophagitis, most likely by inhibiting the synthesis
Table 1 Variance and Tukey comparison of the inflammation response factors ( xˉ ±s, n=10)
Response
factor
IL-1
IL-2
IL-6
IL-8
TNF-α
Control
group
0.09 (0.02)
0.33 (0.06)
98.5 (6.68)
0.31 (0.08)
1.30 (0.11)
Saline-
treated group
0.20 (0.03)abcd
2.23 (0.71)abcd
187.21 (9.59)abcd
0.81 (0.17)abcd
2.56 (0.42)abcd
Low dose ZSG-
treated group
0.16 (0.01)ade
1.52 (0.07)ade
154.79 (9.57)acde
0.60 (0.05)acde
2.02 (0.13)acde
Medium dose ZSG-
treated group
0.14 (0.01)abde
1.23 (0.06)abcd
130.12 (6.47)abde
0.47 (0.04)abe
1.72 (0.07)abde
High dose ZSG-
treated group
0.11 (0.02)bce
0.42 (0.36)bce
111.36 (7.00)bce
0.36 (0.03)be
1.38 (0.15)bce
F
42.84
35.10
156.89
42.00
45.28
P value
0.0000
0.0000
0.0000
0.0000
0.0000
Notes: control group were treated without radiation, but with 10 mL/kg normal saline given by intragastric administration once daily. Sa-
line-treated group were treated undergoing radiation and with 10 mL/kg normal saline given by intragastric administration once daily.
Low, medium and high-dose ZSG-treated groups were treated undergoing radiation and witth 1.15, 2.3, or 4.6 g/kg ZSG by intragastric
administration once a day for 7 days. ISG: Zhuyeshigao granules; IL-1, 2, 6, 8: interleukins-1, 2, 6, 8; TNF-α: tumor necrosis factor-α. aP<
0.05, compared with the control group; bP<0.05, compared with the low-dose ZSG-treated group; cP<0.05, compared with the medi-
um-dose ZSG-treated group; dP<0.05, compared with the high-dose ZSG-treated group; eP<0.05, compared with the saline-treated group.
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and release of interleukins, reducing the generation of
inflammatory mediators, suppressing inflammation,
and protecting tissue integrity.
TNF-α is a pro-inflammatory cytokine, and plays an
important role in initiating the tissue inflammatory re-
action.15 TNF-α damages endothelial cells, increases
vascular permeability, promotes leukocyte adhesion of
vascular endothelial cells, and stimulates IL-1 produc-
tion by vascular endothelial cells, endothelin, and oth-
er inflammatory mediators, leading to tissue inflamma-
tion. In contrast, TNF-α stimulates neutrophil degran-
ulation "outbursts," which produces oxygen free radi-
cals, proteases and lipids, leading to tissue damage.16 In
addition, in inflammatory reactions, TNF-α is synthe-
sized and secreted by mononuclear macrophages, by au-
tocrine and paracrine mechanisms, releasing IL-1,
IL-6, and IL-8, causing a "cascade effect" and aggravat-
ing tissue damage.17 We also observed that serum
TNF-α levels in low, medium, and high-dose
ISG-treated groups are significantly lower than in sa-
line-treated groups (P<0.05). This suggests that ZSG
may prevent development of radiation esophagitis, per-
haps by protecting endothelial cells, maintaining the in-
tegrity of esophagus epithelial cells, reducing inflamma-
tory cell infiltration, reducing vascular permeability, re-
lieving edema, inhibiting generation of IL-1, IL-6, and
IL-8, and reducing the release of inflammatory cells
and inflammatory mediators.
In summary, our results suggest that ZSG may prevent
the development of radiation esophagitis by inhibiting
the synthesis and release of inflammatory factors. How-
ever, human diseases can be treated by Chinese medi-
cine in various ways that function via different targets.
Thus, there remains a need for more research on alter-
native methods to control radiation esophagitis.
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